TLP-019

N/A

Report date: 2025/01/26 16:06:40
NME

Base Information

Drug NameTLP-019
Drug Alias NameHMGB1/RAGE interaction targeting drugs (Science Univ Tokyo/Jikei University/National Cancer Center Research Institute)TLP-019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHigh Mobility Group Protein B1 modulatorsAdvanced glycosylation end product-specific receptor modulators
TargetsHigh Mobility Group Protein B1Advanced glycosylation end product-specific receptor
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTokyo University of Science
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer Center Research InstituteTokyo University of ScienceJikei University
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A